hand dysfunction

May 26, 2016May 26, 2016

Promising Scleroderma Clinical Trial May Improve Hand Dysfunction

News, Scleroderma

Cytori Therapeutics provided a recent update on results from clinical trials assessing the use of Cytori Cell Therapy (ECCS-50) in the treatment of scleroderma-related hand dysfunction. The presentation was made during the 104th Annual Meeting of the ... Read more

May 3, 2016May 3, 2016

Cytori Updates Phase 3 Scleroderma STAR Trial, Enrolls 60th Patient

News, Scleroderma

Cell therapy company Cytori Therapeutics announced that its Phase 3 STAR clinical trial has enrolled and treated its 60th patient, reaching 75 percent of the target enrollment (80 patients). Safety data review ... Read more

September 15, 2015November 6, 2015

Cytori Therapeutics’ Scleroderma Therapy Shows Promising Results After 12 Months of Treatment

News, Scleroderma

Cytori Therapeutics a late stage cell therapy company developing autologous cell therapies from adipose tissue to treat a variety of medical conditions, recently announced the results from a 12-month follow-up of patients ... Read more